Hantavirus and pandemic: Why are we not facing a scenario similar to that of COVID-19?

I have seen a lot of concern in recent days on social media and in the news regarding the current hantavirus outbreak. I believe it’s important to conduct a calm analysis, from the perspectives of virology and epidemiology, to understand why, at least with the evidence available at this time, the risk of this evolving into a pandemic is extremely low.

First, it is important to understand that we are talking about an outbreak. An outbreak means the occurrence of a number of cases greater than expected in a specific place and time. Not every outbreak automatically implies an epidemic, let alone a pandemic. After COVID-19, many of these terms began to blend in public conversation, sometimes generating more anxiety than scientific understanding.

From a virological perspective, hantavirus is a zoonotic virus, primarily adapted to animal reservoirs, especially rodents. Humans generally become infected through the inhalation of contaminated particles from the secretions or excretions of these animals. However, there is a significant difference between a virus capable of infecting humans and a virus that is efficiently adapted to be transmitted from human to human.

And that is precisely the key to this scenario.

For a virus to have true pandemic potential, it must meet several criteria simultaneously: efficient and sustained transmission between people, the ability to maintain continuous chains of infection, community spread, and, in many cases, the capacity for transmission even before the onset of symptoms. That was precisely what made SARS-CoV-2 so complex.

Up to this moment, that is not what we are observing with hantavirus. Epidemiologically, current cases remain sporadic and related to specific exposures. There is no evidence of sustained community transmission or an expansive behavior consistent with a pandemic dynamic.

Many people remember the concept of "R0" that we heard about during the COVID-19 pandemic. R0 represents the average number of people that an infected individual can transmit the virus to in a susceptible population. When a virus maintains a high and sustained R0, cases grow exponentially. In this case, that is not what we are seeing.

It is also important to remember something that often causes confusion: a virus with high lethality does not necessarily have high pandemic capacity. In fact, many highly aggressive viruses struggle to transmit effectively between humans. The pandemic capacity depends much more on transmissibility than on isolated clinical severity.

On the other hand, I find it important to point out that, based on what we have been observing in the news and in the available epidemiological reports, the surveillance, control, and prevention measures being implemented are appropriate and align with recommendations for this type of scenario. This is precisely what a responsible healthcare system should do: to monitor, contain, and prevent, without generating unnecessary alarm.

Epidemiological surveillance is always necessary. Disproportionate fear is not. From my perspective, as an internist specialized in infectious diseases, I believe this situation will not go beyond an outbreak.